<PAGE>

      As filed with the Securities and Exchange Commission on June 7, 2002
                                                      Registration No. 333-_____

================================================================================
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM S-8
                             REGISTRATION STATEMENT
                        UNDER THE SECURITIES ACT OF 1933

                           WRIGHT MEDICAL GROUP, INC.
             (Exact name of registrant as specified in its charter)

             Delaware                                   13-4088127
  (State or other jurisdiction                       (I.R.S. Employer
  of incorporation or organization)                Identification Number)

                                5677 Airline Road
                           Arlington, Tennessee 38002

          (Address, including zip code, of principal executive offices)
     -----------------------------------------------------------------------
                           Wright Medical Group, Inc.
                        2002 Employee Stock Purchase Plan
                            (Full title of the plan)
     -----------------------------------------------------------------------
                                  F. Barry Bays
                      President and Chief Executive Officer
                           Wright Medical Group, Inc.
                                5677 Airline Road
                           Arlington, Tennessee 38002
                                 (901) 867-9971
            (Name, address, including zip code, and telephone number,
                   including area code, of agent for service)
     -----------------------------------------------------------------------
                                    Copy to:
                             Rebecca W. Ballou, Esq.
                       Baker, Donelson, Bearman & Caldwell
                         165 Madison Avenue, 20th Floor
                                Memphis, TN 38103
                                 (901) 526-2000
     -----------------------------------------------------------------------
                         Calculation of Registration Fee

<TABLE>
<CAPTION>
                              Amount to be       Proposed maximum        Proposed maximum         Amount of
 Title of securities to be     registered      offering price per      aggregate offering        registration
        registered                (1)               share (2)                price (2)               fee
----------------------------------------------------------------------------------------------------------------
<S>                          <C>                <C>                     <C>                    <C>
       Common Stock              200,000              $20.68                $4,136,000             $380.51
----------------------------------------------------------------------------------------------------------------
</TABLE>

1.    This Registration Statement covers 200,000 shares of voting common stock,
      $0.01 par value per share, of Wright Medical Group, Inc. (the "Common
      Stock") issuable pursuant to the 2002 Wright Medical Group, Inc. Employee
      Stock Purchase Plan (the "Plan"). In addition, this Registration Statement
      covers an indeterminable number of additional shares of Common Stock as
      may hereafter be offered or issued pursuant to the Plan, to prevent
      dilution resulting from stock splits or similar transactions effected
      without receipt of consideration and pursuant to Rule 416(c) under the
      Securities Act of 1933, as amended (the "Securities Act").
2.    Estimated solely for calculating the amount of the registration fee. The
      registration fee has been calculated pursuant to paragraphs (c) and (h) of
      Rule 457 under the Securities Act based upon the average of the high and
      low sales prices of the Common Stock as reported by the Nasdaq National
      Market on June 5, 2002.


<PAGE>

                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

ITEM 3.  INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

                  The following documents, filed with the Securities and
         Exchange Commission (the "Commission") by Wright Medical Group, Inc., a
         Delaware corporation (the "Company"), are incorporated by reference
         into the Registration Statement:

         (a)      The Company's Annual Report on Form 10-K for the year ended
                  December 31, 2001, filed with the Commission on February 28,
                  2002;

         (b)      The Company's Quarterly Report on Form 10-Q for the quarter
                  ended March 31, 2002, filed with the Commission on May 7,
                  2002;

         (c)      The Company's Current Report on Form 8-K, filed with the
                  Commission on May 13, 2002; and

         (d)      The description of the Common Stock contained in the
                  Prospectus portion of the Company's Form S-1 (Registration No.
                  333-81618) filed with the Commission on February 28, 2002,
                  under the heading "Description of Capital Stock."

                  All documents subsequently filed by the Company with the
         Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the
         Securities Exchange Act of 1934 as amended (the "Exchange Act") prior
         to the filing of a post-effective amendment which indicates that all
         the securities offered hereby have been sold or which deregisters all
         securities then remaining unsold, shall be deemed to be incorporated by
         reference in this Registration Statement and to be a part hereof from
         the date of the filing of such documents with the Commission.

                  The Company was unable to obtain the written consent of Arthur
         Andersen LLP to incorporate by reference in this registration statement
         its report dated February 22, 2002, included in the Company's Annual
         Report on Form 10-K for the year ended December 31, 2001. The absence
         of such consent may limit recovery by investors on certain claims,
         including without limitation, claims arising under Section 11 of the
         Securities Act.

ITEM 4.  DESCRIPTION OF SECURITIES

         Not applicable.

ITEM 5.  INTERESTS OF NAMED EXPERTS AND COUNSEL

         Not applicable.

                                       1
<PAGE>



ITEM 6.  INDEMNIFICATION OF DIRECTORS AND OFFICERS

                  The provisions of the Delaware General Corporation Law
         ("DGCL") and the Company's amended and restated certificate of
         incorporation provide that the Company will, under certain situations,
         indemnify any director, officer, employee or agent of the Company made
         or threatened to be made a party to a proceeding, by reason of the
         former or present official capacity of the person, against judgments,
         penalties, fines, settlements and reasonable expenses, including
         attorneys' fees, incurred by the person in connection with the
         proceeding if certain statutory standards are met. Any such person is
         also entitled, subject to certain limitations, to payment or
         reimbursement of reasonable expenses in advance of the final
         disposition of the proceeding. A proceeding means a threatened, pending
         or completed civil, criminal, administrative, arbitration or
         investigative proceeding, including one by or in the right of the
         Company. Reference is made to Section 145 of the DGCL for a full
         statement of these indemnification rights.

                  The Company also maintains a directors and officers insurance
         policy pursuant to which the directors and officers of the Company are
         insured against liability for actions in their capacity as directors
         and officers.

ITEM 7.  EXEMPTION FROM REGISTRATION CLAIMED

         Not applicable.

ITEM 8.  EXHIBITS

         Exhibit No.       Description of Exhibits
         -----------       -----------------------

         4.1               Wright Medical Group, Inc. 2002 Employee Stock
                           Purchase Plan (incorporated by reference to the
                           Company's Definitive Proxy Statement filed with the
                           Commission on April 30, 2002).

         5                 Opinion of Baker Donelson Bearman & Caldwell
                           concerning the legality of the securities being
                           registered.

         23.1              The Company was unable to obtain the written consent
                           of Arthur Andersen LLP to incorporate by reference
                           its report dated February 28, 2002. See Item 3.

         23.2              Consent of Baker Donelson Bearman & Caldwell
                           (included in Exhibit 5).

         24                Power of Attorney (reference is made to the signature
                           page).


                                       2
<PAGE>




ITEM 9.  UNDERTAKINGS

                  1. The undersigned registrant hereby undertakes:

                  (a) To file, during any period in which offers or sales are
         being made, a post-effective amendment to the Registration Statement:

                  (i) to include any prospectus required by Section 10(a)(3) of
         the Securities Act;

                  (ii) to reflect in the prospectus any facts or events arising
         after the effective date of the Registration Statement (or the most
         recent post-effective amendment thereof) which, individually or in the
         aggregate, represent a fundamental change in the information set forth
         in the Registration Statement;

                  (iii) to include any material information with respect to the
         plan of distribution not previously disclosed in the Registration
         Statement or any material change to such information in the
         Registration Statement;

         provided, however, that paragraphs (a)(i) and (a)(ii) do not apply if
         the information required to be included in a post-effective amendment
         by those paragraphs is contained in periodic reports filed by the
         Company pursuant to Section 13 or Section 15(d) of the Exchange Act
         that are incorporated by reference in the Registration Statement.

                  (b) That, for the purpose of determining any liability under
         the Securities Act, each such post-effective amendment shall be deemed
         to be a new registration statement relating to the securities offered
         therein, and the offering of such securities at that time shall be
         deemed to be the initial bona fide offering thereof.

                  (c) To remove from registration by means of a post-effective
         amendment any of the securities being registered which remain unsold at
         the termination of the offering.

                  2. The undersigned registrant hereby undertakes that, for
         purposes of determining any liability under the Securities Act, each
         filing of the Company's annual report pursuant to Section 13(a) or
         Section 15(d) of the Exchange Act that is incorporated by reference in
         the Registration Statement shall be deemed to be a new registration
         statement relating to the securities offered therein, and the offering
         of such securities at that time shall be deemed to be the initial bona
         fide offering thereof.

                                       3
<PAGE>

                  3. Insofar as indemnification for liabilities arising under
         the Securities Act may be permitted to directors, officers and
         controlling persons of the Company pursuant to the foregoing
         provisions, or otherwise, the Company has been advised that in the
         opinion of the Commission such indemnification is against public policy
         as expressed in the Securities Act and is, therefore, unenforceable. In
         the event that a claim for indemnification against such liabilities
         (other than the payment by the Company of expenses incurred or paid by
         a director, officer or controlling person of the Company in the
         successful defense of any action, suit or proceeding) is asserted by
         such director, officer or controlling person in connection with the
         securities being registered, the Company will, unless in the opinion of
         its counsel the matter has been settled by controlling precedent,
         submit to a court of appropriate jurisdiction the question whether such
         indemnification by it is against public policy as expressed in the
         Securities Act and will be governed by the final adjudication of such
         issue.

                                       4

<PAGE>



                                   SIGNATURES

         Pursuant to the requirements of the Securities Act, the Company
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized on the 7th day of June, 2002.


                                     WRIGHT MEDICAL GROUP, INC.

                                     By: /s/ F. Barry Bays
                                     ------------------------------
                                     F. Barry Bays
                                     President and Chief Executive
                                     Officer


                                POWER OF ATTORNEY

         Each of the undersigned officers and directors of Wright Medical Group,
Inc. hereby severally constitutes and appoints John K. Bakewell as the
attorney-in-fact for the undersigned, in any and all capacities, with full power
of substitution, to sign any and all pre- or post-effective amendments to this
Registration Statement, any subsequent Registration Statement for the same
offering which may be filed pursuant to Rule 462(b) under the Securities Act of
1933, as amended, and any and all pre- or post-effective amendments thereto, and
to file the same with exhibits thereto and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto said
attorney-in-fact full power and authority to do and perform each and every act
and thing requisite and necessary to be done in and about the premises, as fully
to all intents and purposes as he might or could do in person, hereby ratifying
and confirming all that said attorney-in-fact may lawfully do or cause to be
done by virtue hereof.

         Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed by the following persons in the
capacities and on the dates indicated:

<TABLE>
<CAPTION>
Signature                                    Title                                        Date

<S>                                          <C>                                          <C>
/s/ F. BARRY BAYS                            President, Chief Executive
--------------------                         Officer and Director                         June 7, 2002
F. Barry Bays                                (Principal Executive Officer)

/s/ JOHN K. BAKEWELL                         Chief Financial Officer
--------------------                         (Principal Financial Officer                 June 7, 2002
John K. Bakewell                             and Principal
                                             Accounting Officer)

/s/ JAMES T. TREACE
--------------------                         Chairman of the Board                        June 7, 2002
James T. Treace

/s/ RICHARD B. EMMITT
--------------------                         Director                                     June 7, 2002
Richard B. Emmitt

/s/ JAMES E. THOMAS
--------------------                         Director                                     June 7, 2002
James E. Thomas

/s/ THOMAS E. TIMBIE
--------------------                         Director                                     June 7, 2002
Thomas E. Timbie

/s/ ELIZABETH H. WEATHERMAN
--------------------                         Director                                     June 7, 2002
Elizabeth H. Weatherman
</TABLE>

                                       5

<PAGE>

                                INDEX TO EXHIBITS

Exhibit No.       Description of Exhibits
-----------       -----------------------

4.1               Wright Medical Group, Inc. 2002 Employee Stock Purchase Plan
                  (incorporated by reference to the Company's Definitive Proxy
                  Statement filed with the Commission on April 30, 2002).

5                 Opinion of Baker Donelson Bearman & Caldwell concerning the
                  legality of the securities being registered.

23.1              The Company was unable to obtain the written consent of Arthur
                  Andersen LLP to incorporate by reference its report dated
                  February 28, 2002. See Item 3.

23.2              Consent of Baker Donelson Bearman & Caldwell (included in
                  Exhibit 5).

24                Power of Attorney (reference is made to the signature page).



                                       6
[{"type": "S-8", "sequence": "1", "filename": "b318843_s8.txt", "description": "REGISTRATION STATEMENT", "secsgml_size_bytes": 17748}]
{"company-data": {"conformed-name": "WRIGHT MEDICAL GROUP INC", "cik": "0001137861", "assigned-sic": "3842", "irs-number": "134088127", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-90024", "film-number": "02673296"}, "business-address": {"street1": "5677 AIRLINE ROAD", "city": "ARLINGTON", "state": "TN", "zip": "38002", "phone": "9018679971"}}
As filed with the Securities and Exchange Commission on June 7, 2002
                                                      Registration No. 333-_____

================================================================================
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM S-8
                             REGISTRATION STATEMENT
                        UNDER THE SECURITIES ACT OF 1933

                           WRIGHT MEDICAL GROUP, INC.
             (Exact name of registrant as specified in its charter)

             Delaware                                   13-4088127
  (State or other jurisdiction                       (I.R.S. Employer
  of incorporation or organization)                Identification Number)

                                5677 Airline Road
                           Arlington, Tennessee 38002

          (Address, including zip code, of principal executive offices)
     -----------------------------------------------------------------------
                           Wright Medical Group, Inc.
                        2002 Employee Stock Purchase Plan
                            (Full title of the plan)
     -----------------------------------------------------------------------
                                  F. Barry Bays
                      President and Chief Executive Officer
                           Wright Medical Group, Inc.
                                5677 Airline Road
                           Arlington, Tennessee 38002
                                 (901) 867-9971
            (Name, address, including zip code, and telephone number,
                   including area code, of agent for service)
     -----------------------------------------------------------------------
                                    Copy to:
                             Rebecca W. Ballou, Esq.
                       Baker, Donelson, Bearman & Caldwell
                         165 Madison Avenue, 20th Floor
                                Memphis, TN 38103
                                 (901) 526-2000
     -----------------------------------------------------------------------
                         Calculation of Registration Fee
Amount to be       Proposed maximum        Proposed maximum         Amount of
 Title of securities to be     registered      offering price per      aggregate offering        registration
        registered                (1)               share (2)                price (2)               fee
----------------------------------------------------------------------------------------------------------------
Common Stock              200,000              $20.68                $4,136,000             $380.51
----------------------------------------------------------------------------------------------------------------
1.    This Registration Statement covers 200,000 shares of voting common stock,
      $0.01 par value per share, of Wright Medical Group, Inc. (the "Common
      Stock") issuable pursuant to the 2002 Wright Medical Group, Inc. Employee
      Stock Purchase Plan (the "Plan"). In addition, this Registration Statement
      covers an indeterminable number of additional shares of Common Stock as
      may hereafter be offered or issued pursuant to the Plan, to prevent
      dilution resulting from stock splits or similar transactions effected
      without receipt of consideration and pursuant to Rule 416(c) under the
      Securities Act of 1933, as amended (the "Securities Act").
2.    Estimated solely for calculating the amount of the registration fee. The
      registration fee has been calculated pursuant to paragraphs (c) and (h) of
      Rule 457 under the Securities Act based upon the average of the high and
      low sales prices of the Common Stock as reported by the Nasdaq National
      Market on June 5, 2002.
PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

ITEM 3.  INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

                  The following documents, filed with the Securities and
         Exchange Commission (the "Commission") by Wright Medical Group, Inc., a
         Delaware corporation (the "Company"), are incorporated by reference
         into the Registration Statement:

         (a)      The Company's Annual Report on Form 10-K for the year ended
                  December 31, 2001, filed with the Commission on February 28,
                  2002;

         (b)      The Company's Quarterly Report on Form 10-Q for the quarter
                  ended March 31, 2002, filed with the Commission on May 7,
                  2002;

         (c)      The Company's Current Report on Form 8-K, filed with the
                  Commission on May 13, 2002; and

         (d)      The description of the Common Stock contained in the
                  Prospectus portion of the Company's Form S-1 (Registration No.
                  333-81618) filed with the Commission on February 28, 2002,
                  under the heading "Description of Capital Stock."

                  All documents subsequently filed by the Company with the
         Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the
         Securities Exchange Act of 1934 as amended (the "Exchange Act") prior
         to the filing of a post-effective amendment which indicates that all
         the securities offered hereby have been sold or which deregisters all
         securities then remaining unsold, shall be deemed to be incorporated by
         reference in this Registration Statement and to be a part hereof from
         the date of the filing of such documents with the Commission.

                  The Company was unable to obtain the written consent of Arthur
         Andersen LLP to incorporate by reference in this registration statement
         its report dated February 22, 2002, included in the Company's Annual
         Report on Form 10-K for the year ended December 31, 2001. The absence
         of such consent may limit recovery by investors on certain claims,
         including without limitation, claims arising under Section 11 of the
         Securities Act.

ITEM 4.  DESCRIPTION OF SECURITIES

         Not applicable.

ITEM 5.  INTERESTS OF NAMED EXPERTS AND COUNSEL

         Not applicable.

                                       1
ITEM 6.  INDEMNIFICATION OF DIRECTORS AND OFFICERS

                  The provisions of the Delaware General Corporation Law
         ("DGCL") and the Company's amended and restated certificate of
         incorporation provide that the Company will, under certain situations,
         indemnify any director, officer, employee or agent of the Company made
         or threatened to be made a party to a proceeding, by reason of the
         former or present official capacity of the person, against judgments,
         penalties, fines, settlements and reasonable expenses, including
         attorneys' fees, incurred by the person in connection with the
         proceeding if certain statutory standards are met. Any such person is
         also entitled, subject to certain limitations, to payment or
         reimbursement of reasonable expenses in advance of the final
         disposition of the proceeding. A proceeding means a threatened, pending
         or completed civil, criminal, administrative, arbitration or
         investigative proceeding, including one by or in the right of the
         Company. Reference is made to Section 145 of the DGCL for a full
         statement of these indemnification rights.

                  The Company also maintains a directors and officers insurance
         policy pursuant to which the directors and officers of the Company are
         insured against liability for actions in their capacity as directors
         and officers.

ITEM 7.  EXEMPTION FROM REGISTRATION CLAIMED

         Not applicable.

ITEM 8.  EXHIBITS

         Exhibit No.       Description of Exhibits
         -----------       -----------------------

         4.1               Wright Medical Group, Inc. 2002 Employee Stock
                           Purchase Plan (incorporated by reference to the
                           Company's Definitive Proxy Statement filed with the
                           Commission on April 30, 2002).

         5                 Opinion of Baker Donelson Bearman & Caldwell
                           concerning the legality of the securities being
                           registered.

         23.1              The Company was unable to obtain the written consent
                           of Arthur Andersen LLP to incorporate by reference
                           its report dated February 28, 2002. See Item 3.

         23.2              Consent of Baker Donelson Bearman & Caldwell
                           (included in Exhibit 5).

         24                Power of Attorney (reference is made to the signature
                           page).

                                       2
ITEM 9.  UNDERTAKINGS

                  1. The undersigned registrant hereby undertakes:

                  (a) To file, during any period in which offers or sales are
         being made, a post-effective amendment to the Registration Statement:

                  (i) to include any prospectus required by Section 10(a)(3) of
         the Securities Act;

                  (ii) to reflect in the prospectus any facts or events arising
         after the effective date of the Registration Statement (or the most
         recent post-effective amendment thereof) which, individually or in the
         aggregate, represent a fundamental change in the information set forth
         in the Registration Statement;

                  (iii) to include any material information with respect to the
         plan of distribution not previously disclosed in the Registration
         Statement or any material change to such information in the
         Registration Statement;

         provided, however, that paragraphs (a)(i) and (a)(ii) do not apply if
         the information required to be included in a post-effective amendment
         by those paragraphs is contained in periodic reports filed by the
         Company pursuant to Section 13 or Section 15(d) of the Exchange Act
         that are incorporated by reference in the Registration Statement.

                  (b) That, for the purpose of determining any liability under
         the Securities Act, each such post-effective amendment shall be deemed
         to be a new registration statement relating to the securities offered
         therein, and the offering of such securities at that time shall be
         deemed to be the initial bona fide offering thereof.

                  (c) To remove from registration by means of a post-effective
         amendment any of the securities being registered which remain unsold at
         the termination of the offering.

                  2. The undersigned registrant hereby undertakes that, for
         purposes of determining any liability under the Securities Act, each
         filing of the Company's annual report pursuant to Section 13(a) or
         Section 15(d) of the Exchange Act that is incorporated by reference in
         the Registration Statement shall be deemed to be a new registration
         statement relating to the securities offered therein, and the offering
         of such securities at that time shall be deemed to be the initial bona
         fide offering thereof.

                                       3
3. Insofar as indemnification for liabilities arising under
         the Securities Act may be permitted to directors, officers and
         controlling persons of the Company pursuant to the foregoing
         provisions, or otherwise, the Company has been advised that in the
         opinion of the Commission such indemnification is against public policy
         as expressed in the Securities Act and is, therefore, unenforceable. In
         the event that a claim for indemnification against such liabilities
         (other than the payment by the Company of expenses incurred or paid by
         a director, officer or controlling person of the Company in the
         successful defense of any action, suit or proceeding) is asserted by
         such director, officer or controlling person in connection with the
         securities being registered, the Company will, unless in the opinion of
         its counsel the matter has been settled by controlling precedent,
         submit to a court of appropriate jurisdiction the question whether such
         indemnification by it is against public policy as expressed in the
         Securities Act and will be governed by the final adjudication of such
         issue.

                                       4
SIGNATURES

         Pursuant to the requirements of the Securities Act, the Company
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized on the 7th day of June, 2002.

                                     WRIGHT MEDICAL GROUP, INC.

                                     By: /s/ F. Barry Bays
                                     ------------------------------
                                     F. Barry Bays
                                     President and Chief Executive
                                     Officer

                                POWER OF ATTORNEY

         Each of the undersigned officers and directors of Wright Medical Group,
Inc. hereby severally constitutes and appoints John K. Bakewell as the
attorney-in-fact for the undersigned, in any and all capacities, with full power
of substitution, to sign any and all pre- or post-effective amendments to this
Registration Statement, any subsequent Registration Statement for the same
offering which may be filed pursuant to Rule 462(b) under the Securities Act of
1933, as amended, and any and all pre- or post-effective amendments thereto, and
to file the same with exhibits thereto and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto said
attorney-in-fact full power and authority to do and perform each and every act
and thing requisite and necessary to be done in and about the premises, as fully
to all intents and purposes as he might or could do in person, hereby ratifying
and confirming all that said attorney-in-fact may lawfully do or cause to be
done by virtue hereof.

         Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed by the following persons in the
capacities and on the dates indicated:
Signature                                    Title                                        Date
/s/ F. BARRY BAYS                            President, Chief Executive
--------------------                         Officer and Director                         June 7, 2002
F. Barry Bays                                (Principal Executive Officer)

/s/ JOHN K. BAKEWELL                         Chief Financial Officer
--------------------                         (Principal Financial Officer                 June 7, 2002
John K. Bakewell                             and Principal
                                             Accounting Officer)

/s/ JAMES T. TREACE
--------------------                         Chairman of the Board                        June 7, 2002
James T. Treace

/s/ RICHARD B. EMMITT
--------------------                         Director                                     June 7, 2002
Richard B. Emmitt

/s/ JAMES E. THOMAS
--------------------                         Director                                     June 7, 2002
James E. Thomas

/s/ THOMAS E. TIMBIE
--------------------                         Director                                     June 7, 2002
Thomas E. Timbie

/s/ ELIZABETH H. WEATHERMAN
--------------------                         Director                                     June 7, 2002
Elizabeth H. Weatherman
5
INDEX TO EXHIBITS

Exhibit No.       Description of Exhibits
-----------       -----------------------

4.1               Wright Medical Group, Inc. 2002 Employee Stock Purchase Plan
                  (incorporated by reference to the Company's Definitive Proxy
                  Statement filed with the Commission on April 30, 2002).

5                 Opinion of Baker Donelson Bearman & Caldwell concerning the
                  legality of the securities being registered.

23.1              The Company was unable to obtain the written consent of Arthur
                  Andersen LLP to incorporate by reference its report dated
                  February 28, 2002. See Item 3.

23.2              Consent of Baker Donelson Bearman & Caldwell (included in
                  Exhibit 5).

24                Power of Attorney (reference is made to the signature page).

                                       6